Investors
News
Contact
About us
Board of Directors
Management
Our Team
Sustainability
Career
Investors
Inhalers
Inhalers
ICOres
ICOcap
ICOpre
ICOone
ICOone Nasal
Patents
Development services
Development services
Inhalers
Formulation
Pharmaceutical Analysis
Advisory services
Partner with us
Partner with us
Iconovo Accelerator Program
Insights
Replacing injections with inhalation
Boost your business with an innovative inhaler partner
Investors
Search
Menu
Menu
LinkedIn
Iconovo AB (publ) har publicerat årsredovisning för 2022.
Läs årsredovisningen här
Iconovo, Arcede Pharma AB and Lund University receive funding from Swelife to...
Study start for Monash University with inhaled oxytocin in ICOone
Scroll to top